Manages Parisian Family Office. Began Wall Street, 82. Founded investment firm, Native American Advisors. Member, White Earth Chippewa Tribe. Was NYSE/FINRA arb. Conservative. Raised on Native reservations. Pureblood, clot-shot free. In a world elevated on a tech-driven dopamine binge, he trades from Ghost Ranch on the Yellowstone River in MT, his TN farm, Pamelot or CASA TULE', his winter camp in Los Cabos, Mexico. Always been, and will always be, an optimist.

Monday, October 01, 2007


Hythiam says investigators observe significant reduction in methamphetamine cravings and use in study of component of it's PROMETA treatment program published in Mayo Clinic Proceedings Journal. Hythiam announced that the Mayo Clinic Proceedings medical journal published in their October installment, an open-label study by Dr. Harold C. Urschel, III, M.D., M.M.A. of the pharmacological component of the PROMETA Treatment Program for methamphetamine dependence. The study found that this component of the PROMETA Treatment Program persistently reduced methamphetamine cravings and use.

No comments: